These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
400 related items for PubMed ID: 23551241
1. Phenobarbital-induced severe cutaneous adverse drug reactions are associated with CYP2C19*2 in Thai children. Manuyakorn W, Siripool K, Kamchaisatian W, Pakakasama S, Visudtibhan A, Vilaiyuk S, Rujirawat T, Benjaponpitak S. Pediatr Allergy Immunol; 2013 May; 24(3):299-303. PubMed ID: 23551241 [Abstract] [Full Text] [Related]
2. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations. Hsiao YH, Hui RC, Wu T, Chang WC, Hsih MS, Yang CH, Ho HC, Chang YG, Chen MJ, Lin JY, Chen DP, Chang PY, Wu TL, Hung SI, Chung WH. J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988 [Abstract] [Full Text] [Related]
3. Association of HLA genotypes with phenytoin induced severe cutaneous adverse drug reactions in Thai children. Manuyakorn W, Likkasittipan P, Wattanapokayakit S, Suvichapanich S, Inunchot W, Wichukchinda N, Khongkhatithuml C, Thampratankul L, Kamchaisatian W, Benjaponpitak S, Mahasirimongkol S. Epilepsy Res; 2020 May; 162():106321. PubMed ID: 32272329 [Abstract] [Full Text] [Related]
4. Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population. Ramírez E, Bellón T, Tong HY, Borobia AM, de Abajo FJ, Lerma V, Moreno Hidalgo MA, Castañer JL, Cabañas R, Fiandor A, González-Ramos J, Herranz P, Cachafeiro L, González-Herrada C, González O, Aramburu JA, Laosa O, Hernández R, Carcas AJ, Frías J. Pharmacol Res; 2017 Jan; 115():168-178. PubMed ID: 27888155 [Abstract] [Full Text] [Related]
5. Association of HLA genotypes with phenobarbital hypersensitivity in children. Manuyakorn W, Mahasirimongkol S, Likkasittipan P, Kamchaisatian W, Wattanapokayakit S, Inunchot W, Visudtibhan A, Wichukchinda N, Benjaponpitak S. Epilepsia; 2016 Oct; 57(10):1610-1616. PubMed ID: 27554620 [Abstract] [Full Text] [Related]
6. Association of HLA-B*1502 and *1511 allele with antiepileptic drug-induced Stevens-Johnson syndrome in central China. Sun D, Yu CH, Liu ZS, He XL, Hu JS, Wu GF, Mao B, Wu SH, Xiang HH. J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):146-150. PubMed ID: 24496695 [Abstract] [Full Text] [Related]
8. Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population. Chang CC, Ng CC, Too CL, Choon SE, Lee CK, Chung WH, Hussein SH, Lim KS, Murad S. Pharmacogenomics J; 2017 Mar; 17(2):170-173. PubMed ID: 26927288 [Abstract] [Full Text] [Related]
11. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Locharernkul C, Loplumlert J, Limotai C, Korkij W, Desudchit T, Tongkobpetch S, Kangwanshiratada O, Hirankarn N, Suphapeetiporn K, Shotelersuk V. Epilepsia; 2008 Dec; 49(12):2087-91. PubMed ID: 18637831 [Abstract] [Full Text] [Related]
12. Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions. Amstutz U, Shear NH, Rieder MJ, Hwang S, Fung V, Nakamura H, Connolly MB, Ito S, Carleton BC, CPNDS clinical recommendation group. Epilepsia; 2014 Apr; 55(4):496-506. PubMed ID: 24597466 [Abstract] [Full Text] [Related]
13. Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand. Rattanavipapong W, Koopitakkajorn T, Praditsitthikorn N, Mahasirimongkol S, Teerawattananon Y. Epilepsia; 2013 Sep; 54(9):1628-38. PubMed ID: 23895569 [Abstract] [Full Text] [Related]
17. The association of HLA B*15:02 allele and Stevens-Johnson syndrome/toxic epidermal necrolysis induced by aromatic anticonvulsant drugs in a South Indian population. Devi K. Int J Dermatol; 2018 Jan; 57(1):70-73. PubMed ID: 29076187 [Abstract] [Full Text] [Related]
18. HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients. Satapornpong P, Pratoomwun J, Rerknimitr P, Klaewsongkram J, Nakkam N, Rungrotmongkol T, Konyoung P, Saksit N, Mahakkanukrauh A, Amornpinyo W, Khunarkornsiri U, Tempark T, Wantavornprasert K, Jinda P, Koomdee N, Jantararoungtong T, Rerkpattanapipat T, Wang CW, Naisbitt D, Tassaneeyakul W, Ariyachaipanich M, Roonghiranwat T, Pirmohamed M, Chung WH, Sukasem C. Front Immunol; 2021 Jan; 12():661135. PubMed ID: 34017337 [Abstract] [Full Text] [Related]
19. HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain. Kulkantrakorn K, Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Prabmechai N, Vannaprasaht S, Chumworathayi P, Chen P, Sritipsukho P. Pain Pract; 2012 Mar; 12(3):202-8. PubMed ID: 21676164 [Abstract] [Full Text] [Related]
20. Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs. Klaewsongkram J, Sukasem C, Thantiworasit P, Suthumchai N, Rerknimitr P, Tuchinda P, Chularojanamontri L, Srinoulprasert Y, Rerkpattanapipat T, Chanprapaph K, Disphanurat W, Chakkavittumrong P, Tovanabutra N, Srisuttiyakorn C, ThaiSCAR study group. J Allergy Clin Immunol Pract; 2019 Jan; 7(1):219-227.e4. PubMed ID: 29800753 [Abstract] [Full Text] [Related] Page: [Next] [New Search]